“Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland” (2007) Swiss Medical Weekly, 137(2122), pp. 317–322. doi:10.4414/smw.2007.11716.